Guest: Dr. Kevin D'Amour, ViaCyte
"It is encouraging. No one has ever done anything quite like this before."
That is Dr. Kevin D'Amour's take on a device designed to change lives.
He is leading a San Diego-based research team that has FDA approval to develop a stem cell treatment for Type 1 Diabetes. The promise lies in the delivery of "a stem cell that has great proliferative power to make many cells, and to treat many patients."
D’Amour points out that the proliferative power of the cell needs to be harnessed to produce islet cells. "We call that differentiation, or the process of differentiation, where the immature cells become more mature cells."
To date, ten patients have been implanted with the device. Phase Two is set to start in 2016.
We invited Dr. Paula Gordon to join us for a Conversation That Matters about the current quality of medical care women are being provided in breast health in BC.
We invited Dr. Jillian Belbin, the President of the BC Dental Association, to join us for a Conversation That Matters about ensuring BC residents have access to superior dental care in a timely and affordable manner.
We invited Katie Fitzmaurice of Invest Vancouver to join us for a Conversation That Matters about the dynamic expansion to Vancouver’s Tech Centre and what lies ahead.
We invited Louis Dron, the CEO of Redwood AI, to join us for a Conversation That Matters about the convergence of advanced chemistry, AI, and addressing a missing link in the drug crisis in Canada.